TS-011 | m-entrepreneurship.com

Product Name :
TS-011

Search keywords :
TS-011

drugId :
null

Target Vo:
Cytochrome P450

Target Vo Short Name :
CYPs

Moa_Name:
Cytochrome P450 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Taisho Pharmaceutical Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Stroke

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&L
VEGFA Antibody
BTK Antibody (YA816): BTK Antibody (YA816) is a non-conjugated and Mouse origined monoclonal antibody about 76 kDa, targeting to BTK (5B12). It can be used for WB,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts